BridgeMD
The role of brain neurotransmission in fatigue
EU CTIS ID: 2024-514038-19-00
What this study is testing
To investigate the role of neurotransmitters in fatigue
- Phase III and phase IV (Integrated)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- 18-35 years old
- Healthy male and female individuals
- No use of medications (contraceptives are allowed)
- No indication of risk in general fatigue, depression and burnout
- Non-smoking
You likely can't join if
- Pregnancy
- Allergies to specific substances utilized in the current study
- Injuries of any kind in the past six months that hinder participation
- History of suffering from any mental/psychiatric disorder
- Participation in any concomitant care or research trials
- Suffering from color vision deficiencies
See the full eligibility criteria
- 18-35 years old
- Healthy male and female individuals
- No use of medications (contraceptives are allowed)
- No indication of risk in general fatigue, depression and burnout
- Non-smoking
- Pregnancy
- Allergies to specific substances utilized in the current study
- Injuries of any kind in the past six months that hinder participation
- History of suffering from any mental/psychiatric disorder
- Participation in any concomitant care or research trials
- Suffering from color vision deficiencies
- Suffering from any chronic health condition diagnosed by a medical professional
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.